Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure (SPINE CARE)

September 15, 2025 updated by: Niteesh K. Choudhry, MD, PhD, Brigham and Women's Hospital

Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure - Randomized Clinical Trial

Low back and neck pain are among the leading causes of medical visits, lost productivity and disability. There is an urgent need to identify effective and efficient ways of helping subjects with acute spine pain while guiding practitioners towards high-value care. This trial will be a block and cluster-randomized open-label multi-centered pragmatic randomized clinical trial comparing healthcare spending and clinical outcomes for subjects with spine pain of less than three months' duration, in whom there are no red flag signs or symptoms. Subjects will be randomized to one of three treatment strategies: (1) usual primary care provider-led care; (2) usual PCP-led care with spine pain treatment directed by the Identify, Coordinate, and Enhanced decision making (ICE) care model, and (3) usual PCP-led care with spine pain treatment directed by the Individualized Postural Therapy (IPT) care model. Our outcomes of interest will be spine-related healthcare utilization at one year as well as pain and functionality of the study participants.

Study Overview

Study Type

Interventional

Enrollment (Actual)

3087

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Phoenix, Arizona, United States, 85255
        • HonorHealth Medical Group
    • California
      • Laguna Hills, California, United States, 92653
        • Marwan A. Edris, MD
      • North Hollywood, California, United States, 91606
        • Teresa S. Sligh, MD
      • Oxnard, California, United States, 93030
        • Augusto Focil, MD
    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University Medical Center
    • Texas
      • Houston, Texas, United States, 77013
        • Carlos R. Herrera, MD
      • Houston, Texas, United States, 77017
        • Luis Zepeda, MD
      • Houston, Texas, United States, 77051
        • Bernadette U. Iguh, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with back or neck pain of ≤ 3 months' duration. All patients must have spine pain with or without radiation to the extremities or the head
  • Age ≥ 18 years
  • Willing and able to provide informed consent

Exclusion Criteria:

  • Patients with symptoms attributed to the spine but without actual pain in the spine (e.g. those with cervicogenic headache without neck pain)
  • Currently pregnant
  • Currently receiving disability benefits, worker's compensation, or involved in litigation for a workplace injury
  • Currently enrolled in another intervention trial for the management of acute back or neck pain
  • Cancer that is metastatic or being actively treated. (i.e chemotherapy, radiation, surgery)
  • History of receiving active therapy for back or neck pain in the past 3 months (7+ consecutive days of narcotic use, 6+ sessions of PT, chiropractic care, acupuncture, postural therapy, or other spine therapy delivered by a trained provider)
  • History of spine surgery or spine injections/ablation in the past 6 months
  • Severe, active psychosis or major depression inhibiting ability to physically participate in intervention
  • Red Flag Symptoms (fever, night sweats, unintentional weight loss, bowel or bladder dysfunction, neurologic weakness, history of intravenous drug use)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual PCP led care
Primary care provider will direct patients' care pathway.
Experimental: Identify, Coordinated, Enhanced (ICE) Decision Making
Subjects seeking care at a clinic assigned to this arm will receive the ICE care model through referral by their primary care provider. The ICE care model was developed by the Clinical Excellence Research Center at Stanford University based on a review of the peer-reviewed literature for adult subjects with incident neck or back pain less than six weeks in duration who are not using high-dose opioid medications or receiving spine-related long-term disability payments.
Experimental: Individualized Postural Therapy (IPT)
IPT involves the evaluation of a subject's posture to identify postural and alignment deviations and, based on this, a personalized corrective exercise program is prescribed. This method does involve the use of prescription medications, surgery, or manipulation. A treatment course typically lasts eight sessions over eight weeks. In order to allow for the consistent delivery of this arm of the study at multiple study-sites across the country, IPT will be delivered by The Egoscue Method. Egoscue was founded in 1971 and has 25 clinics worldwide.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Spine-related Cost of Care at One Year
Time Frame: One year
Measured by patient self-report
One year
Change in Pain
Time Frame: Three months

Measured by Oswestry Disability Index The Oswestry Disability Index (ODI) captures pain related disability based on patient self-report.

The ODI ranges from 0 (best) to 100 (worst). The Minimal clinically important difference (MCID) for ODI in patients with spine pain is 6 points.

The change in participant-level pain related disability from baseline to 3 months using the Oswestry Disability Index has been reported.

Reference: Fairbank JCT, Couper J, Davies JB, O'Brien JP. The Oswestry Low Back Pain Disability Questionnaire. Physiotherapy. 1980;66:271-273

Three months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain
Time Frame: One year

Measured by Oswestry Disability Index The Oswestry Disability Index (ODI) captures pain related disability based on patient self-report.

The ODI ranges from 0 (best) to 100 (worst). The MCID for ODI in patients with spine pain is 6 points.

The change in participant-level pain related disability from baseline to 12 months using the Oswestry Disability Index has been reported.

Reference: Fairbank JCT, Couper J, Davies JB, O'Brien JP. The Oswestry Low Back Pain Disability Questionnaire. Physiotherapy. 1980;66:271-273

One year
Quality of Life (EQ5D-5L VAS Scores)
Time Frame: One year

EuroQol 5-Dimensional Visual Analogue Scale (EQ-5D-5L VAS) by the EuroQol Group measures patient's self-rated health-related quality of life on a vertical visual analog scale.

EQ-5D-5L VAS range from 0 to 100, with 100 indicating the best score. The MCID for the EQ-5D-5L visual analogue scale ranges from 5.3 to 10.5.

The health-related quality of life at 12 months using the EQ-5D-5L VAS has been reported.

One year
Self-efficacy
Time Frame: One year

The Lorig self-efficacy functioning sub-scale items ask individuals how confident they are in performing certain daily activities.

Lorig self-efficacy functioning sub-scale scores range from 0 to 100, with 100 indicating the best score. The MCID for the Lorig self-efficacy scale has not been established.

The patient-reported self-efficacy at 12 months using the Lorig self-efficacy functioning sub-scale has been reported.

Reference: Lorig K, Chastain RL, Ung E, Shoor S, Holman HR. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum. 1989 Jan;32(1):37-44. doi: 10.1002/anr.1780320107. PMID: 2912463.

One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Niteesh K Choudhry, MD, PhD, Brigham and Women's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 5, 2017

Primary Completion (Actual)

March 31, 2021

Study Completion (Actual)

June 30, 2021

Study Registration Dates

First Submitted

March 14, 2017

First Submitted That Met QC Criteria

March 14, 2017

First Posted (Actual)

March 20, 2017

Study Record Updates

Last Update Posted (Estimated)

September 17, 2025

Last Update Submitted That Met QC Criteria

September 15, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Back Pain

Clinical Trials on Usual PCP led care

Subscribe